Chris Rallis

(Mr. Chris Rallis)

Currently holds positions in Aeolus Pharmaceuticals Inc and Tenax Therapeutics Inc

Positions

Position Company Period
Independent Director Aeolus Pharmaceuticals Inc June 28, 2004 -
Independent Director Tenax Therapeutics Inc Dec. 15, 2011 -
Chris Rallis's trades of Fennec Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-04-11 2025-04-11 S Sale
1,409 -2.6%
4.95
USD 6,975
1,409 -2.6% 4.95 USD 6,975
2025-02-14 2025-02-14 S Sale
1,186 -2.2%
6.82
USD 8,089
1,186 -2.2% 6.82 USD 8,089
2024-12-02 2024-12-02 S Sale
6,409 -10.9%
6.14
USD 39,351
6,409 -10.9% 6.14 USD 39,351
2024-10-10 2024-10-08 S Sale
1,406 -2.8%
4.53
USD 6,369
1,406 -2.8% 4.53 USD 6,369
2024-07-08 2024-07-05 S Sale
1,173 -2.5%
6.03
USD 7,073
1,173 -2.5% 6.03 USD 7,073
2024-04-15 2024-04-15 S Sale
800 -1.8%
10.45
USD 8,360
800 -1.8% 10.45 USD 8,360
2024-03-27 2024-03-26 S Sale
2,114 -4.9%
10.97
USD 23,191
2,114 -4.9% 10.97 USD 23,191
2023-12-28 2023-12-26 S Sale
1,390 -3.0%
10.90
USD 15,151
1,390 -3.0% 10.90 USD 15,151
2023-11-20 2023-11-20 PS Planned sale
269 -0.6%
8.25
USD 2,219
269 -0.6% 8.25 USD 2,219
2023-08-18 2023-08-18 S Sale
673 -1.5%
7.85
USD 5,283
673 -1.5% 7.85 USD 5,283
2023-07-24 2023-07-24 S Sale
6,796 -13.4%
8.17
USD 55,523
6,796 -13.4% 8.17 USD 55,523
2023-07-06 2023-07-06 S Sale
2,207 -7.1%
8.47
USD 18,693
2,207 -7.1% 8.47 USD 18,693
2023-05-19 2023-05-19 PS Planned sale
925 -2.9%
7.36
USD 6,808
925 -2.9% 7.36 USD 6,808
2023-05-19 2023-05-19 PS Planned sale
833 -2.5%
7.36
USD 6,131
833 -2.5% 7.36 USD 6,131
2022-11-17 2022-11-17 PS Planned sale
333 -1.1%
7.99
USD 2,661
333 -1.1% 7.99 USD 2,661
// ... existing code ... // ... rest of the file ...